CHAPEL HILL, N.C., Apr 30, 2010 (BUSINESS WIRE) --POZEN Inc. (NASDAQ: POZN),announced today that management
will hold a live webcast on May 3, 2010 at 8:30 a.m. Eastern time to
discuss regulatory updates regarding VIMOVO(TM) (naproxen and esomeprazole
magnesium) delayed-release tablets. The webcast can be accessed on
POZEN's website at www.pozen.com
and will be archived and available for replay.
POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical
company committed to transforming medicine that transforms lives. Since
its founding in 1996, POZEN has successfully created novel pharmacologic
agents primarily for pain and pain-related conditions by combining
existing drug therapies that result in superior patient outcomes. Moving
forward, POZEN is poised to become a model 21st century
pharmaceutical company dedicated to ensuring that they produce
cost-effective, evidence-based medicines; take a fresh approach to
sales, marketing and medical education; and deliver high-quality,
affordable pharmaceuticals to their customers. The Company's common
stock is traded on The NASDAQ Stock Market under the symbol "POZN". For
more detailed company information, including copies of this and other
press releases, please visit: www.pozen.com.
SOURCE: POZEN Inc.
Bill Hodges, Chief Financial Officer, 919-913-1030